Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F03%3A23033052" target="_blank" >RIV/68378050:_____/03:23033052 - isvavai.cz</a>

Alternative codes found

RIV/00023736:_____/03:00000004

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.

Original language description

Moderately immunogenic HPV16-associated tumours, MHC class I+ and class I-, were used to examine the adjuvant effects of IL-2 and dendritic cells for surgical therapy. It has been found that in both types of tumours recombinant IL-2 and IL-2 gene-modified vaccines substantially reduced the tumour recurrence rate and inhibited tumour growth. The dendritic cells were effective only in surgical therapy of MHC class I+ tumours.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2003

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Vaccine

ISSN

0264-410X

e-ISSN

—

Volume of the periodical

21

Issue of the periodical within the volume

9-10

Country of publishing house

NL - THE KINGDOM OF THE NETHERLANDS

Number of pages

6

Pages from-to

891-896

UT code for WoS article

—

EID of the result in the Scopus database

—